|
🐢
|
Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer d
20 auth.
C. Fernández-Martos,
C. Pericay,
J. Aparicio,
A. Salud,
M. Safont,
B. Massutí,
R. Vera,
P. Escudero,
J. Maurel,
E. Marcuello,
...
J. Mengual,
E. Saigí,
R. Estevan,
M. Mira,
S. Polo,
A. Hernández,
M. Gallén,
F. Arias,
J. Serra,
V. Alonso
|
8 |
2010 |
8
🐢
|
|
🐜
|
Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial†.
15 auth.
C. Fernández-Martos,
X. García-Albéniz,
C. Pericay,
J. Maurel,
J. Aparicio,
C. Montagut,
M. Safont,
A. Salud,
R. Vera,
B. Massutí,
...
P. Escudero,
V. Alonso,
C. Bosch,
M. Martin,
B. Minsky
|
8 |
2015 |
8
🐜
|
|
🐜
|
Sorafenib and bevacizumab combination targeted therapy in advanced neuroendocrine tumour: a phase II study of Spanish Neuroendocrine Tumour Group (GETNE0801).
10 auth.
D. Castellano,
J. Capdevila,
J. Sastre,
V. Alonso,
M. Llanos,
R. García-Carbonero,
...
J. L. Manzano Mozo,
I. Sevilla,
I. Durán,
R. Salazar
|
6 |
2013 |
6
🐜
|
|
🐜
|
Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer
13 auth.
C. Grávalos,
C. Gómez-Martín,
F. Rivera,
I. Alés,
B. Queralt,
A. Márquez,
U. Jiménez,
V. Alonso,
R. García-Carbonero,
J. Sastre,
...
R. Colomer,
H. Cortés-Funes,
A. Jimeno
|
6 |
2011 |
6
🐜
|
|
🐜
|
Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
21 auth.
Barbara Nuñez-Valdovinos,
A. Carmona-Bayonas,
P. Jiménez-Fonseca,
J. Capdevila,
Á. Castaño-Pascual,
M. Benavent,
Jose Javier Pi Barrio,
A. Teule,
V. Alonso,
A. Custodio,
...
M. Marazuela,
A. Segura,
A. Beguiristain,
M. Llanos,
María Purificación Martínez del Prado,
J. Díaz-Pérez,
D. Castellano,
I. Sevilla,
C. Lopez,
T. Alonso,
R. García-Carbonero
|
6 |
2018 |
6
🐜
|
|
🐜
|
Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II study
16 auth.
M. Martin-Richard,
B. Massutí,
E. Pineda,
V. Alonso,
M. Mármol,
D. Castellano,
E. Fonseca,
A. Galán,
M. Llanos,
M. Sala,
...
C. Pericay,
F. Rivera,
J. Sastre,
A. Segura,
M. Quindós,
P. Maisonobe
|
6 |
2013 |
6
🐜
|
|
🐜
|
Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer
29 auth.
J. Codony-Servat,
M. Cuatrecasas,
E. Asensio,
Carla Montironi,
A. Martínez-Cardús,
M. Marín-Aguilera,
C. Horndler,
E. Martínez-Balibrea,
M. Rubini,
P. Jares,
O. Reig,
I. Victoria,
L. Gaba,
M. Martin-Richard,
V. Alonso,
...
P. Escudero,
C. Fernández-Martos,
J. Feliu,
J. Méndez,
M. Méndez,
J. Gallego,
A. Salud,
F. Rojo,
A. Castells,
A. Prat,
R. Rosell,
X. García-Albéniz,
J. Camps,
J. Maurel
|
6 |
2017 |
6
🐜
|
|
🐜
|
Preoperative chemotherapy in patients with intermediate-risk rectal adenocarcinoma selected by high-resolution magnetic resonance imaging: the GEMCAD 0801 Phase II Multicenter Trial.
20 auth.
C. Fernández-Martos,
G. Brown,
R. Estevan,
A. Salud,
C. Montagut,
J. Maurel,
M. Safont,
J. Aparicio,
J. Feliu,
R. Vera,
...
V. Alonso,
J. Gallego,
M. Martín,
M. Pera,
E. Sierra,
J. Serra,
S. Delgado,
J. Roig,
Jesús Santos,
C. Pericay
|
6 |
2014 |
6
🐜
|
|
🐜
|
Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial
20 auth.
J. Vidal,
D. Casadevall,
B. Bellosillo,
C. Pericay,
R. García-Carbonero,
F. Losa,
Laia Layos,
V. Alonso,
J. Capdevila,
J. Gallego,
...
R. Vera,
A. Salud,
M. Martin-Richard,
M. Nogué,
E. Cillán,
J. Maurel,
I. Faull,
V. Raymond,
C. Fernández-Martos,
C. Montagut
|
5 |
2021 |
5
🐜
|
|
🐜
|
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)
29 auth.
J. Capdevila,
N. Fazio,
C. Lopez,
A. Teule,
J. Valle,
S. Tafuto,
A. Custodio,
N. Reed,
M. Raderer,
E. Grande,
R. García-Carbonero,
P. Jiménez-Fonseca,
J. Hernando,
Alberto Bongiovanni,
F. Spada,
...
V. Alonso,
L. Antonuzzo,
A. Spallanzani,
A. Berruti,
A. La Casta,
I. Sevilla,
P. Kump,
D. Giuffrida,
X. Merino,
L. Trejo,
P. Gajate,
I. Matos,
A. Lamarca,
T. Ibrahim
|
5 |
2021 |
5
🐜
|
